These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 37269541)

  • 1. Microbes, metabolites and muscle: Is the gut-muscle axis a plausible therapeutic target in Duchenne muscular dystrophy?
    Marullo AL; O'Halloran KD
    Exp Physiol; 2023 Sep; 108(9):1132-1143. PubMed ID: 37269541
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alterations in Notch signalling in skeletal muscles from mdx and dko dystrophic mice and patients with Duchenne muscular dystrophy.
    Church JE; Trieu J; Chee A; Naim T; Gehrig SM; Lamon S; Angelini C; Russell AP; Lynch GS
    Exp Physiol; 2014 Apr; 99(4):675-87. PubMed ID: 24443351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological Inhibition of PKCθ Counteracts Muscle Disease in a Mouse Model of Duchenne Muscular Dystrophy.
    Marrocco V; Fiore P; Benedetti A; Pisu S; Rizzuto E; Musarò A; Madaro L; Lozanoska-Ochser B; Bouché M
    EBioMedicine; 2017 Feb; 16():150-161. PubMed ID: 28089792
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exploring the Gut Microbiota-Muscle Axis in Duchenne Muscular Dystrophy.
    Mostosi D; Molinaro M; Saccone S; Torrente Y; Villa C; Farini A
    Int J Mol Sci; 2024 May; 25(11):. PubMed ID: 38891777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypochlorous acid exposure impairs skeletal muscle function and Ca
    Lea TA; Panizza PM; Arthur PG; Bakker AJ; Pinniger GJ
    J Physiol; 2023 Dec; 601(23):5257-5275. PubMed ID: 37864413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting gut dysbiosis against inflammation and impaired autophagy in Duchenne muscular dystrophy.
    Kalkan H; Pagano E; Paris D; Panza E; Cuozzo M; Moriello C; Piscitelli F; Abolghasemi A; Gazzerro E; Silvestri C; Capasso R; Motta A; Russo R; Di Marzo V; Iannotti FA
    EMBO Mol Med; 2023 Mar; 15(3):e16225. PubMed ID: 36594243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microbiota dysbiosis influences immune system and muscle pathophysiology of dystrophin-deficient mice.
    Farini A; Tripodi L; Villa C; Strati F; Facoetti A; Baselli G; Troisi J; Landolfi A; Lonati C; Molinaro D; Wintzinger M; Gatti S; Cassani B; Caprioli F; Facciotti F; Quattrocelli M; Torrente Y
    EMBO Mol Med; 2023 Mar; 15(3):e16244. PubMed ID: 36533294
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intermittent PTH treatment improves bone and muscle in glucocorticoid treated Mdx mice: A model of Duchenne Muscular Dystrophy.
    Yoon SH; Grynpas M; Mitchell J
    Bone; 2019 Apr; 121():232-242. PubMed ID: 30716510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-Term Protective Effect of Human Dystrophin Expressing Chimeric (DEC) Cell Therapy on Amelioration of Function of Cardiac, Respiratory and Skeletal Muscles in Duchenne Muscular Dystrophy.
    Siemionow M; Langa P; Brodowska S; Kozlowska K; Zalants K; Budzynska K; Heydemann A
    Stem Cell Rev Rep; 2022 Dec; 18(8):2872-2892. PubMed ID: 35590083
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pre-clinical evaluation of N-acetylcysteine reveals side effects in the mdx mouse model of Duchenne muscular dystrophy.
    Pinniger GJ; Terrill JR; Assan EB; Grounds MD; Arthur PG
    J Physiol; 2017 Dec; 595(23):7093-7107. PubMed ID: 28887840
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Levels of α7 integrin and laminin-α2 are increased following prednisone treatment in the mdx mouse and GRMD dog models of Duchenne muscular dystrophy.
    Wuebbles RD; Sarathy A; Kornegay JN; Burkin DJ
    Dis Model Mech; 2013 Sep; 6(5):1175-84. PubMed ID: 23846963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inflammasome Activity in the Skeletal Muscle and Heart of Rodent Models for Duchenne Muscular Dystrophy.
    Onódi Z; Szabó PL; Kucsera D; Pokreisz P; Dostal C; Hilber K; Oudit GY; Podesser BK; Ferdinandy P; Varga ZV; Kiss A
    Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37239853
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Striated muscle activator of Rho signalling (STARS) overexpression in the mdx mouse enhances muscle functional capacity and regulates the actin cytoskeleton and oxidative phosphorylation pathways.
    Sadler KJ; Gatta PAD; Naim T; Wallace MA; Lee A; Zaw T; Lindsay A; Chung RS; Bello L; Pegoraro E; Lamon S; Lynch GS; Russell AP
    Exp Physiol; 2021 Jul; 106(7):1597-1611. PubMed ID: 33963617
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of sphingolipid de novo synthesis counteracts muscular dystrophy.
    Laurila PP; Luan P; Wohlwend M; Zanou N; Crisol B; Imamura de Lima T; Goeminne LJE; Gallart-Ayala H; Shong M; Ivanisevic J; Place N; Auwerx J
    Sci Adv; 2022 Jan; 8(4):eabh4423. PubMed ID: 35089797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human dystrophin expressing chimeric (DEC) cell therapy ameliorates cardiac, respiratory, and skeletal muscle's function in Duchenne muscular dystrophy.
    Siemionow M; Langa P; Harasymczuk M; Cwykiel J; Sielewicz M; Smieszek J; Heydemann A
    Stem Cells Transl Med; 2021 Oct; 10(10):1406-1418. PubMed ID: 34291884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increasing taurine intake and taurine synthesis improves skeletal muscle function in the mdx mouse model for Duchenne muscular dystrophy.
    Terrill JR; Pinniger GJ; Graves JA; Grounds MD; Arthur PG
    J Physiol; 2016 Jun; 594(11):3095-110. PubMed ID: 26659826
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phosphodiesterase 4 inhibitor and phosphodiesterase 5 inhibitor combination therapy has antifibrotic and anti-inflammatory effects in mdx mice with Duchenne muscular dystrophy.
    Nio Y; Tanaka M; Hirozane Y; Muraki Y; Okawara M; Hazama M; Matsuo T
    FASEB J; 2017 Dec; 31(12):5307-5320. PubMed ID: 28798156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impairments in left ventricular mitochondrial bioenergetics precede overt cardiac dysfunction and remodelling in Duchenne muscular dystrophy.
    Hughes MC; Ramos SV; Turnbull PC; Edgett BA; Huber JS; Polidovitch N; Schlattner U; Backx PH; Simpson JA; Perry CGR
    J Physiol; 2020 Apr; 598(7):1377-1392. PubMed ID: 30674086
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growth Hormone Increases Bone Toughness and Decreases Muscle Inflammation in Glucocorticoid-Treated Mdx Mice, Model of Duchenne Muscular Dystrophy.
    Yoon SH; Grynpas MD; Mitchell J
    J Bone Miner Res; 2019 Aug; 34(8):1473-1486. PubMed ID: 31188496
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hemojuvelin is a novel suppressor for Duchenne muscular dystrophy and age-related muscle wasting.
    Zhang P; He J; Wang F; Gong J; Wang L; Wu Q; Li W; Liu H; Wang J; Zhang K; Li M; Huang X; Pu C; Li Y; Jiang F; Wang F; Min J; Chen X
    J Cachexia Sarcopenia Muscle; 2019 Jun; 10(3):557-573. PubMed ID: 30884219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.